Next Article in Journal
YY1/BCCIP Coordinately Regulates P53-Responsive Element (p53RE)-Mediated Transactivation of p21Waf1/Cip1
Next Article in Special Issue
Magnesium Is a Key Player in Neuronal Maturation and Neuropathology
Previous Article in Journal
The Role of Macrophage in the Pathogenesis of Osteoporosis
Previous Article in Special Issue
TRPM7, Magnesium, and Signaling
Article Menu
Issue 9 (May-1) cover image

Export Article

Open AccessReview

Magnesium and Drugs

Academy of Micronutrient Medicine, Zweigertstr. 55, 45130 Essen, Germany
Int. J. Mol. Sci. 2019, 20(9), 2094;
Received: 7 March 2019 / Revised: 19 April 2019 / Accepted: 24 April 2019 / Published: 28 April 2019
(This article belongs to the Special Issue Magnesium in Differentiation and Development)
PDF [631 KB, uploaded 28 April 2019]
  |     |  


Several drugs including diuretics and proton-pump inhibitors can cause magnesium loss and hypomagnesemia. Magnesium and drugs use the same transport and metabolism pathways in the body for their intestinal absorption, metabolism, and elimination. This means that when one or more drug is taken, there is always a potential risk of interaction with the magnesium status. Consequently the action of a drug may be adversely affected by magnesium (e.g., magnesium, calcium, and zinc can interfere with the gastrointestinal absorption of tetracycline antibiotics) and simultaneously the physiological function of minerals such as magnesium may be impaired by a drug (e.g., diuretics induce renal magnesium loss). Given the ever-increasing number of drugs on the market and the frequency with which they are used, greater attention must be paid in daily medical and pharmaceutical practice focused in particular on the adverse effects of drug therapy on magnesium status in order to minimize the potential risk to the health of patients. View Full-Text
Keywords: Magnesium; drugs; drug-induced magnesium deficiency; proton-pump inhibitors; diuretics; TRPM6; SLC41A1 Magnesium; drugs; drug-induced magnesium deficiency; proton-pump inhibitors; diuretics; TRPM6; SLC41A1

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).

Share & Cite This Article

MDPI and ACS Style

Gröber, U. Magnesium and Drugs. Int. J. Mol. Sci. 2019, 20, 2094.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top